Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that the U.S. Patent and Trademark Office has issued an expanded patent for LunaRich, Reliv’s exclusive nutritional ingredient. The updated patent further protects LunaRich technology as it relates to the soy peptide lunasin’s mechanism of action for lowering LDL cholesterol levels.
Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy’s documented health benefits. LunaRich optimizes bioactive lunasin more than any other source available today.
“Novel ingredients like LunaRich that boast a spectrum of nutritional technologies often require continual patent updates,” said Dr. Carl W. Hastings, Reliv vice chairman and chief scientific officer. “Reliv is committed to securing the strongest patent portfolio possible for this remarkable nutritional ingredient.”
Reliv also holds a composition